The document lists the attendees of the MEDTECH 2012 conference. There were over 100 attendees from various organizations listed, including their names, titles, and organizations. The attendees represented companies in the medical device, biotech, and regulatory fields.
Leardon Solutions is a global product development, engineering, and manufacturing services company who is passionate about helping small/medium businesses, entrepreneurs, and start-ups turn their ideas and concepts into revenue generating products. Leardon Solutions applies decades of collective knowledge and experience in medical, sports, and consumer products for companies looking to collaborate on all or a part of their product design and/or manufacturing.
We’re all camping at UX Camp West, so I thought I’d use the metaphor of a tent to share with you my view on the field of User Experience. I will describe the 7 poles of the tent's structure (research, design, evaluation, implementation, business, strategy, and management) and show you some random objects that I found in its corners. It is my goal that afterwards, we can all appreciate the beauty of the big tent, and realise how we contribute to a happy stay.
Whether it's directly improving patient care or helping lower costs to provide more access to healthcare, organizations are continuing to use IT to move the needle for an industry that is at a pivotal point in innovation.
Learn how our innovative storage solutions can help your organization meet its healthcare Big Data challenges: http://www.netapp.com/us/solutions/industry/healthcare/
Keck Graduate Institute of Applied Life Sciences is dedicated to education and research aimed at translating into practice the power and potential of the life sciences for the benefit of society.
Leardon Solutions is a global product development, engineering, and manufacturing services company who is passionate about helping small/medium businesses, entrepreneurs, and start-ups turn their ideas and concepts into revenue generating products. Leardon Solutions applies decades of collective knowledge and experience in medical, sports, and consumer products for companies looking to collaborate on all or a part of their product design and/or manufacturing.
We’re all camping at UX Camp West, so I thought I’d use the metaphor of a tent to share with you my view on the field of User Experience. I will describe the 7 poles of the tent's structure (research, design, evaluation, implementation, business, strategy, and management) and show you some random objects that I found in its corners. It is my goal that afterwards, we can all appreciate the beauty of the big tent, and realise how we contribute to a happy stay.
Whether it's directly improving patient care or helping lower costs to provide more access to healthcare, organizations are continuing to use IT to move the needle for an industry that is at a pivotal point in innovation.
Learn how our innovative storage solutions can help your organization meet its healthcare Big Data challenges: http://www.netapp.com/us/solutions/industry/healthcare/
Keck Graduate Institute of Applied Life Sciences is dedicated to education and research aimed at translating into practice the power and potential of the life sciences for the benefit of society.
David MacLeod, Chair, MacLeod Review, spoke on engaging managers and staff for success at The King's Fund's Second Annual NHS Leadership and Management Summit.
Now in its 7th year, The PharmaForce event (October 29-31, 2012 | Westin Princeton At Forrestal Village | Princeton, NJ) tackles the latest sales and marketing strategies faced by the pharma and biotech industry—From measuring the ROI of your promotional efforts to achieving the ideal channel mix to navigating new pricing and reimbursement models. How? With speakers who are actual practitioners, thought leaders who are rethinking the traditional commercial model and leading the way with integrated, customer centric commercial strategies.
Event brochure for the upcoming Global Clinical Outsourcing Forum in May, Munich. With presentations, case studies and roundtable discussions from leading industry experts from Genzyme, Pfizer, Antisoma, Merck Serono and Grünenthal amoung others
Technology Forecast: Reshaping the workforce with the new analyticsPwC Russia
В обзоре Technology Forecast: Reshaping the workforce with the new analytics исследуется воздействие новых аналитических инструментов и культуры работы с данными, которую организации могут создать с помощью новых инструментов и услуг по анализу данных.
Immunotherapy Europe Speakers - The Perfect Combination of Strategy and Innov...Michael Adeniya
Phacilitate's Immunotherapy Europe will bring leaders in the field together. big phama, biotech, payers, HTAs, regulators and investors. See what's being discussed at Europe's ONLY commercial meeting for Immunotherapy!
David MacLeod, Chair, MacLeod Review, spoke on engaging managers and staff for success at The King's Fund's Second Annual NHS Leadership and Management Summit.
Now in its 7th year, The PharmaForce event (October 29-31, 2012 | Westin Princeton At Forrestal Village | Princeton, NJ) tackles the latest sales and marketing strategies faced by the pharma and biotech industry—From measuring the ROI of your promotional efforts to achieving the ideal channel mix to navigating new pricing and reimbursement models. How? With speakers who are actual practitioners, thought leaders who are rethinking the traditional commercial model and leading the way with integrated, customer centric commercial strategies.
Event brochure for the upcoming Global Clinical Outsourcing Forum in May, Munich. With presentations, case studies and roundtable discussions from leading industry experts from Genzyme, Pfizer, Antisoma, Merck Serono and Grünenthal amoung others
Technology Forecast: Reshaping the workforce with the new analyticsPwC Russia
В обзоре Technology Forecast: Reshaping the workforce with the new analytics исследуется воздействие новых аналитических инструментов и культуры работы с данными, которую организации могут создать с помощью новых инструментов и услуг по анализу данных.
Immunotherapy Europe Speakers - The Perfect Combination of Strategy and Innov...Michael Adeniya
Phacilitate's Immunotherapy Europe will bring leaders in the field together. big phama, biotech, payers, HTAs, regulators and investors. See what's being discussed at Europe's ONLY commercial meeting for Immunotherapy!
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
1. ATTENDEES
Name Title Organization
Rand Henke CEO Adarza Biosystems, Inc.
Ashley Lewis Business Development Manager Ahern, Murphy & Associates
Beth Bornick Technology Transfer Officer Albany Medical College
Catherine James CEO Alzheimer's Association, Central New York Chapter
Harold Meckler Vice President, Science & Technology AMRI
Wendy Quinn Associate Librarian AMRI
Sean Novak Application Engineering/NPD Manager Anoplate Corporation
Ed Robb Corporate Project Manager Applied Medical Coatings
Paul Buckley President Applied Sciences Group, Inc.
John Conway New Business Development Applied Sciences Group, Inc.
Kim Grant Business Development Manager Applied Sciences Group, Inc.
Mika Newton Vice President of Sales and Marketing Archimedes Inc.
Rich Turner Chief of Staff Assemblyman Mark Johns
Anne Costa Assistant Director Aurora of CNY
Roger Hungerford CEO Axiom Equity Partners, LLC
Steve Steiber Senior Partner Axxiom Healthcare Alliance
Glenn Davies Director, Regulatory Affairs Bausch + Lomb
Nancy Fehrman RA Sr. Specialist Bausch + Lomb
Barb Klube-Falso Specialist, Regulatory Affairs Bausch + Lomb
Jennifer Knicley Sr. Manager Bausch + Lomb
Heather Michaels Specialist, Regulatory Affairs Bausch + Lomb
Jennifer Murray Sr. Manager, Regulatory Affairs Bausch + Lomb
Samantha Duffy Sr. RA Specialist Bausch + Lomb, Inc.
Michael Bovalino Executive Vice President Biospherix
Kevin Murray Sales Manager Biospherix
Al Di Rienzo President & CEO Blue Highway
David Eilers VP, Business Development Blue Highway
Laila Kobrossy Audi Technology Commercialization Manager Blue Highway
Thomas Kucharski President & CEO Buffalo Niagara Enterprise
Alan Rosenhoch Business Development Manager Buffalo Niagara Enterprise
Patrick Bolger Director, Clinical & Business Affairs, CMSU CACT Alfred University NYS College of Ceramics
Patrick Emmerling Technology Licensing Manager CACT Alfred University NYS College of Ceramics
Katherine Burns Medical Product Manager Caplugs
Fred Zeyfang Senior VP Engineering & Business Development Caplugs
John Pardo Director, Regulatory Affairs & Quality Systems Carestream Health
Jennifer Tegan Partner Cayuga Venture Fund
Jeffrey Holmes Managing Director Cephas Capital Partners
Dana Schmidt Life Sciences Underwriting Specialist Chubb Group of Insurance Companies
Christopher Barry President ClarElast, LLC
Griffin Jones Consultant Congruent Compliance
Tim Evans Intellectual Property Attorney ConMed Corporation
Mary Reed Sr. Dir. Global Branding & Marketing Communications CooperVision, Inc.
Gail Bauman Associate Director, Corporate and Foundation Relations Cornell University
Michele van de Walle Director, CCMR Industrial Partnerships Cornell University
2. MEDTECH 2012 ATTENDEES
Bruce Kirk Director, Corporate Innovation Effectiveness Corning, Inc.
Katie Edwards Deputy Director of Biomedical Sciences CUBRC
Carl Herrgesell Principal Consultant CVH Consultants
Joe Kenny Director of Account Management DTx Inc.
Robert Short Strategic Account Manager DTx Inc.
David Veniskey Partner EFP Rotenberg, LLP
Evangeline Loh Vice President of Global Regulatory Affairs Emergo Group
Michelle Bonn President Expedient Trade
Todd Steffes Vice President, Healthcare Practice FICO
Mark Dente Chief Medical Officer GE Health Care
Larry Gilroy President Gilroy, Kernan & Gilroy
Mary Salamone Commercial Lines Account Executive Gilroy, Kernan & Gilroy
Brandon Hoffman Vice President, Sales & Marketing Graphic Controls LLC
Carla Marshall Product Manager Graphic Controls LLC
Matt Hurlbutt Vice President & COO Greater Rochester Enterprise
Heather Rosecrans Senior Regulatory Advisor Greenleaf Health LLC
Dan Schultz Sr. Vice President, Medical Devices & Combination Products Greenleaf Health LLC
Graeme Roberts Big Wheel GrowMotor
Cynthia Antonucci Partner Harris Beach PLLC
Anne Schneiderman Partner Harris Beach PLLC
Gerard van Grinsven President & CEO Henry Ford West Bloomfield Hospital
John Boger Partner Heslin Rothenberg Farley & Mesiti, P.C.
Bela Musits Venture Partner High Peaks Venture Partners
Jean Kase Executive Director, The Entrepreneurs Network High Tech Rochester
Mike Riedlinger Director, Rochester BioVenture Center High Tech Rochester
Holly Hoehner Partner Hiscock & Barclay
Monika Bhatt Associate Hodgson Russ LLP
Amy Goerss Attorney Hodgson Russ LLP
Bethany Trachtenberg Senior Associate Hodgson Russ LLP
Matthew Smith Global Relationship Manager HSBC Bank USA
Jessica Crawford Independent Consultant
Halyna Mekker Independent Consultant
Kristen Mucitelli-Heath Independent Consultant
Peter Robinson Independent Consultant
Dave Sherburne Director, Global R&D Effectiveness Independent Consultant
Edward Wright Independent Consultant
Jack McGowan Project Manager Insyte Consulting
Richard Paddock Director, Med Tech International Trade Administration
Dave Glocker President Isoflux Incorporated
Jack Greco Business Development Isoflux Incorporated
David Horan Regional Executive JPMorgan Chase Bank
Peter Hessney Director, Consulting and Advisory Services KensaGroup, LLC
Thomas Richardson VP Strategic Consulting, Chief Marketing Officer KJT Group
Carissa Childs Associate LeClairRyan
Michael Goldman Partner LeClairRyan
Ted Merkel Partner LeClairRyan
Megan Thisse Associate LeClairRyan
Tate Tischner Partner LeClairRyan
Page 2 of 5
3. MEDTECH 2012 ATTENDEES
Betsy Glavin Administrative Assoicate Litron Laboratories
Carol Tometsko CEO Litron Laboratories
Rory Burrill Director of Business Development Logical Images, Inc.
Kathleen Arntsen President & CEO Lupus Foundation of Mid and Northern New York
Carolynn Frearson Consultant MedTech
Scott Sutton Principal Microbiology Network
Paul Elwell Sales Director Moog Medical Devices Group
Patrick Polito Microbiologist Moog Medical Devices Group
Yang Xiao Marketing Manager Moog Medical Devices Group
Jeffrey Champagne Senior Manager, Business Development Nerac, Inc.
Donna Mitchell-Magaldi Project Analyst, Medical Devices Nerac, Inc.
Raymond Walsh Business Development Manager Nerac, Inc.
Mark Johns Assembly District 135 New York State Assembly
Steve Kapp President nFocal Inc.
Dick Van Belzen Managing Director Northpoint Advisors
Amy Castronova President Novatek Communications, Inc.
Jan Peartree Director of Technical Documentation & Editing Solutions Novatek Communications, Inc.
David Pesce Director of Training & eLearning Solutions Novatek Communications, Inc.
Renata Bator Business Development Associate NYS Center of Excellence in Bioinformatics & Life Sciences
Jennifer Giegel Commercialization Assistant NYS Center of Excellence in Bioinformatics & Life Sciences
Marnie LaVigne Associate Vice President for Economic Development NYS Center of Excellence in Bioinformatics & Life Sciences
Kenneth Warrington Business Development Executive NYS Center of Excellence in Bioinformatics & Life Sciences
Rajiv Ramchandra Staff Engineer NYS Pollution Prevention Institute
Sarah Clark Deputy State Director Office of Senator Kirsten Gillibrand
Brad Boyer Senior Regulatory Affairs Associate Ortho Clinical Diagnostics
Ted Farrell Vice President, Program Management Ortho Clinical Diagnostics
Gaozhen Hang Regulatory Affairs Associate Ortho Clinical Diagnostics
Holly Hillberg Vice President, R&D Ortho Clinical Diagnostics
Banu Sankaran Manager, Partner Development Ortho Clinical Diagnostics
Ann Vu Site Director, QRC Ortho Clinical Diagnostics
Gang Wu Research Professor Pace University
Linda Trevenen Director of Marketing Excellence and Market Intelligence Philips Home Health Solutions
Randy Clower IP Attorney Phillips Lytle LLP
Ben Harp Chief Operating Officer Polymer Conversions, Inc.
Karen Klemmer Director of Quality Systems Polymer Conversions, Inc.
John Murphy Senior Director of Clinical Analytics, Consulting Quintiles
Davis Walp Head of Value Based Solutions Quintiles
Bryan Luce Founder and Managing Director Reliance Capital Partners
Per Stromhaug Technology Transfer Coordinator Research Foundation of State University of New York
Bill Bond Director, Intellectual Property Management Rochester Institute of Technology
Mike Dwyer Director of Research Relations Rochester Institute of Technology
Dan Phillips Associate Professor, Department of Electrical Engineering Rochester Institute of Technology
Yasmeen Smalley Photographer Rochester Institute of Technology
Dennis Hoffman Quality & Regulatory Practice Manager RTEmd
James Janicki EVP, Engineering & Quality RTEmd
Bob Ruppenthal President RTEmd
Thomas Schumacher Manager Sustaining Engineering RTEmd
Courtney Smith MedTech Intern S.I. Newhouse School of Public Communications
Page 3 of 5
4. MEDTECH 2012 ATTENDEES
Raimundo Archibold Managing Director Schwartz Heslin Group
Mark Wagner President Sensorcon
Joe Miano Vice President of Sales SoPark Corporation
Gerry Murak President and CEO SoPark Corporation
Rupa Shanmugam Vice President of Operations SoPark Corporation
Tracie Reeves Hartman Marketing Coordinator Sparton Medical
Kevin Webb Business Development Sparton Medical
Isabelle Bichindaritz Asst. Professor, Human Computer Intraction (HCI) SUNY Oswego
Lorrie Clemo Provost SUNY Oswego
Kayla Lynskey MedTech Intern SUNY Oswego ('12)
Cindy Dowd Greene Associate VP for Industry Relations SUNY Upstate Medical University
Jennifer Crisp Assistant Director Syracuse University
Brian Scott National Sales Representative Tapecon Inc.
Carl Kennedy FDA & Global Medical Device Program Leader Thermo Fisher Scientific
Joel Benzel Chief Executive Officer TouchStream Solutions
Cor Drost CEO and CTO Transonic Systems, Inc.
Tim McCall Director, Rochester Export Assistance Center U.S. Commercial Service
Scott Tenenbaum Associate Professor of Nanobioscience University at Albany
Gina Demeo Student, Biomedical Engineering University of Rochester
Cyrus Lambotte Student, Biomedical Engineering University of Rochester
Catherine Polyakov Student, Biomedical Engineering University of Rochester
Sarah Wayson Student, Biomedical Engineering University of Rochester
Tianmiao Zhou Student, Biomedical Engineering University of Rochester
Bradford Berk CEO University of Rochester Medical Center
John Fahner-Vihtelic Deputy Director University of Rochester Medical Center
Marjorie Hunter Associate Vice President University of Rochester Medical Center
Scott Steele Director, Research Alliances University of Rochester Medical Center
Harl Tolbert Associate Director, Office of Technology Transfer University of Rochester Medical Center
Matan Rapoport Licensing Associate URMC
Weimin Kaufman Licensing Associate URMC OTT
Colleen Costello CEO & Co-founder VitalIV, LLC
James Peterson CTO & Co-founder VitalIV, LLC
Max Kunz CEO Volpi USA
Brandon Yee Business Development Manager Volpi USA
Jamie Arnold Manager, Public Relations & Internal Communication Welch Allyn
Roger Bonenfant Associate General Counsel Welch Allyn
Brian Buys Global Category Manager Welch Allyn
Robin Delaney Welch Allyn
Scott Gucciardi Executive VP & Chief Marketing Officer Welch Allyn
Mark Hall Sr. Director FP&A--The Americas Welch Allyn
Doug Linquest SVP Global Category Marketing Welch Allyn
Kelley Murphy Global Cat. Director Welch Allyn
Pooja Sinha Welch Allyn
John Steadman VP, Business Development Welch Allyn
Sal Strods VP, Product Development, Research and Development Welch Allyn
Kimberly Townsend Senior Counsel and Director, Government Affairs Welch Allyn
Joe Smith Chief Medical Officer West Wireless
Katie McGuire Patent Attorney - Partner Woods Oviatt Gilman LLP
Page 4 of 5
5. MEDTECH 2012 ATTENDEES
Douglas Smith Ph.D, J.D. Woods Oviatt Gilman LLP
Ashica Ambu Research Analyst World Trade Center Buffalo Niagara
Thomas Bienias Director of International Development World Trade Center Buffalo Niagara
Carrie DeGeorge Vice President World Trade Center Buffalo Niagara
Christopher Johnston President World Trade Center Buffalo Niagara
Chris Scalisi Program Manager World Trade Center Buffalo Niagara
Jim Hengst CEO ZeptoMetrix Corporation
Pascale Plamondon Senior Bacteriologist ZeptoMetrix Corporation
Peter Trabold Manager, Bacteriology ZeptoMetrix Corporation
John Brennan Business Advisor & Executive Coach
Brian Johnston Research Director
Page 5 of 5